On the stock market since 2021, it operates in the world of technology. It has 540 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
An average decline of 15% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Clearly below the class average.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Clearly below the class average.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Growth: Sales growth trails the sector average.
An investor who bought at the very peak is down 92% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $123.6M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 73 buys and 53 sells. Management buying with its own money is usually read as a good sign.
The average analyst price target is $3.17 — 117% above today’s price.
A loss of $8.1M against $123.6M in annual sales. And on top of that, sales fell from the year before.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 23/100. For a turnaround signal, the stock first needs to close the gap with the market.
The growth engine is running at low revs right now. Report-card grade: 43/100.
On our five-subject report card, BLND sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BLND is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (55/100) says the stock isn’t cheap.